News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Broom Colin MD
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2022 |
4
| Broom Colin MD (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 5,339 shares
@ $0.1902, valued at
$1k
|
|
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| Broom Colin MD (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Bought 10,177 shares
@ $2.0309, valued at
$20.7k
|
|
| 08/26/2019 |
4/A
| Broom Colin MD (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 10,177 shares
@ $2.07, valued at
$21.1k
|
|
| 08/21/2019 |
4
| Broom Colin MD (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 10,177 shares
@ $2.07, valued at
$21.1k
Exercised 33,750 options to buy
@ $0 |
|
| 08/01/2019 |
4
| Broom Colin MD (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 35,000 options
@ $0 |
|
| 06/25/2018 |
4
| Broom Colin MD (CEO & Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Bought 5,000 shares
@ $3.72, valued at
$18.6k
|
|
| 05/23/2018 |
4
| Broom Colin MD (CEO & Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Bought 10,000 shares
@ $4.6, valued at
$46k
|
|
| 02/02/2018 |
4
| Broom Colin MD (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 200,000 options
@ $0
Granted 67,500 restricted stock units
@ $0 |
|
| 09/26/2017 |
4
| Broom Colin MD (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Bought 2,588 shares
@ $8.35, valued at
$21.6k
|
|
| 06/27/2017 |
4
| Broom Colin MD (CEO) has filed a Form 4 on Nabriva Therapeutics Plc|
Txns:
| Acquired 1,595 shares
@ $0
Acquired 155,817 shares
@ $0
Acquired 158,270 options
@ $0
Acquired 196,900 options
@ $0
Acquired 151,000 options
@ $0
Acquired 261,000 options
@ $0 |
|
| 02/09/2017 |
4
| Broom Colin MD (CEO) has filed a Form 4 on Nabriva Therapeutics AG|
Txns:
| Granted 26,100 options
@ $0 |
|
| 12/30/2016 |
3
| Broom Colin MD (CEO) has filed a Form 3 on Nabriva Therapeutics AG |
| 02/24/2015 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 24,313 shares
@ $46, valued at
$1.1M
Disposed/sold 36,000 options to buy
@ $4.95, valued at
$178.2k
Disposed/sold 3,816 restricted stock units
@ $0
Disposed/sold 29,759 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 3,816 restricted stock units
@ $0 |
|
| 02/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/28/2014 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Unknown transaction of 154,058 shares
@ $50, valued at
$7.7M
Granted 48,878 shares
@ $0
Disposed/sold 48,878 shares
@ $0
Disposed/sold 34,932 options to buy
@ $19.73, valued at
$689.2k
Disposed/sold 33,439 options to buy
@ $15.24, valued at
$509.6k
Disposed/sold 49,975 options to buy
@ $9.99, valued at
$499.3k
Disposed/sold 52,593 options to buy
@ $13.5, valued at
$710k
Disposed/sold 36,920 options to buy
@ $8.86, valued at
$327.1k
Disposed/sold 50,000 options to buy
@ $11.31, valued at
$565.5k
Disposed/sold 40,261 options to buy
@ $17.84, valued at
$718.3k
Disposed/sold 40,261 options to buy
@ $17.98, valued at
$723.9k
|
|
| 01/10/2014 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 6,914 shares
@ $49.8, valued at
$344.3k
Paid exercise price by delivering 1,551 shares
@ $49.8, valued at
$77.2k
Paid exercise price by delivering 2,773 shares
@ $49.8, valued at
$138.1k
Paid exercise price by delivering 1,166 shares
@ $49.8, valued at
$58.1k
Paid exercise price by delivering 1,175 shares
@ $49.8, valued at
$58.5k
Paid exercise price by delivering 2,231 shares
@ $49.8, valued at
$111.1k
Paid exercise price by delivering 2,196 shares
@ $49.8, valued at
$109.4k
Paid exercise price by delivering 2,134 shares
@ $49.8, valued at
$106.3k
Exercised 90,000 options to buy
@ $1.84, valued at
$165.6k
Exercised 10,000 options to buy
@ $5.91, valued at
$59.1k
Exercised 13,080 options to buy
@ $8.86, valued at
$115.9k
|
|
| 06/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2013 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 15,188 restricted stock units
@ $0 |
|
| 01/07/2013 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 34,570 options to buy
@ $23.37, valued at
$807.9k
|
|
| 12/27/2012 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 17,500 shares
@ $22.5315, valued at
$394.3k
Exercised 17,500 options to buy
@ $1.84, valued at
$32.2k
|
|
| 05/23/2012 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 403 restricted stock units
@ $0 |
|
| 01/19/2012 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 2,278 restricted stock units
@ $0 |
|
| 01/06/2012 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 27,265 options to buy
@ $28.15, valued at
$767.5k
|
|
| 12/27/2011 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Exercised 17,500 options to buy
@ $1.84, valued at
$32.2k
|
|
| 12/14/2011 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 17,670 shares
@ $23.5041, valued at
$415.3k
Sold 22,330 shares
@ $23.5, valued at
$524.8k
Exercised 17,670 options to buy
@ $7.05, valued at
$124.6k
Exercised 22,330 options to buy
@ $7.05, valued at
$157.4k
|
|
| 11/08/2011 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 19,800 shares
@ $21, valued at
$415.8k
Sold 200 shares
@ $21.01, valued at
$4.2k
Exercised 20,000 options to buy
@ $5.91, valued at
$118.2k
|
|
| 11/02/2011 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 20,495 shares
@ $20.4223, valued at
$418.6k
Sold 24,121 shares
@ $20.0506, valued at
$483.6k
Exercised 20,495 options to buy
@ $3.14, valued at
$64.4k
Exercised 24,121 options to buy
@ $3.14, valued at
$75.7k
|
|
| 10/19/2011 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 2,258 restricted stock units
@ $0 |
|
| 07/19/2011 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 1,577 restricted stock units
@ $0 |
|
|
|
|